Patent: 9,220,705

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,220,705

Title:	Method of treating colorectal cancer
Abstract:	The present invention relates to the use of certain platinum compounds including [PtCl.sub.2(cis-1,4-diaminocyclohexane)], or combinations of these compounds with a variety of other agents for treating and/or preventing the progression of colorectal cancer in mammals. In particular, the invention provides methods of treating and/or preventing oxaliplatin-refractory colorectal cancer in mammals.
Inventor(s):	Hoeschele; James David (Plymouth, MI), Margiotta; Nicola (Barletta, IT), Gandin; Valentina (Tarzo, IT), Petruzzella; Emanuele (Molfetta, IT), Marzano; Cristina (Padua, IT)
Assignee:
Application Number:	14/199,858
Patent Claims:	see list of patent claims

Details for Patent 9,220,705

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Imclone	ERBITUX	cetuximab	VIAL; INTRAVENOUS	125084	001	2004-06-18	Start Trial		2039-02-26	RX	Orphan	search
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	001	2004-02-26	Start Trial		2039-02-26	RX	Orphan	search
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	002	2004-02-26	Start Trial		2039-02-26	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,220,705

Subscribe to access the full database, or Start Trial
Country	Patent Number	Publication Date
United States of America	2014255394	Sep 11, 2014
United States of America	2016096855	Apr 07, 2016
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.